Simply Wall St.42d agobearish
Jazz Pharmaceuticals (JAZZ) Expands AbCellera Tie Up As Zepzelca Trial Misses GoalJazz Pharmaceuticals (NasdaqGS:JAZZ) expanded its collaboration with AbCellera Biologics to develop next-generation T-cell multispecific antibodies for gastrointestinal and other solid tumors. The company reported top-line results from the Phase 3 LAGOON trial of Zepzelca in second-line small cell lung cancer, which did not meet its primary endpoint. Zepzelca continues to have its first-line approval based on prior studies, and Jazz Pharmaceuticals is in discussions with the FDA about future...
